What is the primary objective of GMP?

The primary objective of GMP is to ensure products are consistently produced and controlled to meet predefined quality standards, preventing contamination, mix-ups, mislabeling, and variability through preventive controls rather than end-product testing alone. This encompasses the "5 Ps"—People, Products, Procedures, Processes, and Premises—as defined in frameworks like FDA 21 CFR Parts 210/211 and EU EudraLex Volume 4.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP guidelines. This includes contract manufacturers (CMOs), suppliers of starting materials, and entities in supply chains for regulated markets, with the sponsor retaining ultimate accountability via technical/quality agreements.

Does GMP require an external audit or third-party certification?

GMP does not mandate third-party certification but requires regular regulatory inspections by authorities like FDA or EMA, plus internal audits and self-inspections. External audits are essential for suppliers and contract sites, aligned with PIC/S and ICH Q7 expectations for independent quality oversight.

How often should an assessment for GMP be performed?

GMP assessments, including internal audits and self-inspections, must be conducted at planned intervals per a risk-based schedule, typically annually, with more frequent reviews for high-risk areas. Product Quality Reviews (PQR) occur annually per 21 CFR §211.180(e), and requalification follows change control or maintenance triggers.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP results in regulatory actions including Form 483 observations, Warning Letters, import alerts, product recalls, substantial fines (e.g., via FDA consent decrees), manufacturing halts, and potential criminal liability. Historical cases like Elixir Sulfanilamide demonstrate patient harm, leading to market exclusion and multimillion-dollar remediation costs.

An GMP be mapped to other international frameworks?

Yes, GMP maps closely to ICH Q7 (API GMP), ICH Q9 (QRM), and ICH Q10 (PQS), with global convergence via PIC/S and MRAs. Core elements like validation, CAPA, and quality units align across FDA, EU, and WHO regimes, enabling harmonized multi-jurisdictional compliance.

What is the first step to begin implementing GMP?

The first step to implement GMP is conducting a comprehensive gap analysis against applicable regulations (e.g., 21 CFR 211 or EU GMP) to produce a Validation Master Plan (VMP) defining scope, risks, and remediation roadmap. This executive-sponsored assessment prioritizes high-risk areas like facilities and documentation.

What is the primary objective of ISO 31000?

ISO 31000’s primary objective is to provide principles, a framework, and process for managing risk to create and protect value. It defines risk as the effect of uncertainty on objectives, enabling organizations to systematically identify, analyze, evaluate, treat, monitor, and report risks across any context.

Who is legally or professionally required to comply with ISO 31000?

No organization is legally required to comply with ISO 31000, as it provides voluntary guidelines rather than mandatory requirements. It applies universally to any organization—public, private, large or small—where professionals in governance, risk, or operations seek to enhance decision-making and resilience.

Does ISO 31000 require an external audit or third-party certification?

No, ISO 31000 does not require external audit or third-party certification. As guidelines rather than auditable requirements, alignment is demonstrated through internal governance, records, and evidence of principles, framework, and process application.

How often should an assessment for ISO 31000 be performed?

ISO 31000 assessments should be performed iteratively, with monitoring and review conducted continually and formally as needed based on context changes. The dynamic principle mandates periodic reassessments triggered by new information, incidents, or environmental shifts, integrated into governance rhythms.

What are the consequences of non-compliance with ISO 31000?

There are no direct legal consequences for non-compliance with ISO 31000, since it is a non-certifiable guideline. Indirect risks include poor decision-making, operational losses, regulatory scrutiny in aligned regimes, and eroded stakeholder trust from unmanaged uncertainty on objectives.

An ISO 31000 be mapped to other international frameworks?

Yes, ISO 31000 can be mapped to other international frameworks as its foundational principles, framework, and process support integration. Its generic structure aligns with management systems, providing a common risk language for consistent application across domains.

What is the first step to begin implementing ISO 31000?

The first step to implement ISO 31000 is securing leadership commitment and establishing the risk management framework per Clause 5. Top management must issue a policy, define integration into governance, assign roles, and design context-specific criteria before scaling the process.

Standards Comparison

GMP vs ISO 31000

GMP

Mandatory

1963

Regulatory standards ensuring pharmaceutical manufacturing quality consistency

ISO 31000

Voluntary

2018

International guidelines for enterprise risk management

Quick Verdict

GMP enforces manufacturing controls for pharmaceuticals to ensure product safety, while ISO 31000 provides voluntary risk management guidelines for all organizations. Companies adopt GMP for regulatory compliance and ISO 31000 to enhance decision-making and resilience.

Manufacturing Quality

GMP

Good Manufacturing Practice (GMP) regulations

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Independent quality unit approves materials and batches
Validated processes and equipment qualification required
Risk-based Quality Risk Management (QRM) integration
Comprehensive documentation ensures full traceability
Preventive controls block contamination and mix-ups

Risk Management

ISO 31000

ISO 31000:2018 Risk management — Guidelines

Cost

€€€

Complexity

Medium

Implementation Time

12-18 months

Key Features

Eight principles guiding effective risk management
Framework emphasizing leadership commitment
Iterative six-step risk process
Customizable to any organization context
Non-certifiable guidelines for value creation

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

GMP Details

What It Is

Good Manufacturing Practice (GMP), including cGMP (21 CFR Parts 210/211), EU GMP (EudraLex Volume 4), and WHO GMP, is a regulatory framework enforcing minimum standards for manufacturing controls. Its primary purpose is preventing contamination, mix-ups, and variability in pharmaceuticals, biologics, and related products through preventive, risk-based systems rather than end-product testing alone.

Key Components

5 Ps pillars: People, Premises, Processes, Procedures, Products.
Core elements: Quality Management System (PQS), validation, documentation, training, facility controls, CAPA, change control.
Built on ICH Q9/Q10 (QRM, lifecycle QMS); no fixed control count, but comprehensive subparts/chapters.
Compliance via inspections, no central certification but site approvals.

Why Organizations Use It

Mandated for market access; reduces recalls, liability, ensures supply reliability. Strategic benefits: operational efficiency, patient protection, global harmonization via PIC/S/ICH. Builds regulator trust, enhances reputation.

Implementation Overview

Phased: gap analysis, Validation Master Plan, qualification (IQ/OQ/PQ), training, audits. Applies to pharma/biologics manufacturers globally; high complexity for facilities/processes. Ongoing audits, no single certification.

ISO 31000 Details

What It Is

ISO 31000:2018, Risk management — Guidelines is an international standard providing non-certifiable guidelines for systematic risk management. Its primary purpose is to help organizations of any size or sector manage uncertainty affecting objectives, using a principles-based, iterative approach focused on creating and protecting value.

Key Components

Three pillars: 8 principles (e.g., integrated, customized, dynamic), framework (leadership, integration, design, evaluation), and process (communication, assessment, treatment, monitoring).
No fixed controls; flexible, tailored implementation.
Built on PDCA cycle for continual improvement.
Non-certifiable; self-assessed alignment via governance and evidence.

Why Organizations Use It

Enhances decision-making, resilience, and opportunity capture.
Meets stakeholder expectations for governance without legal mandates.
Reduces losses, improves efficiency, builds trust.
Competitive edge in strategy, procurement, M&A.

Implementation Overview

Phased: leadership buy-in, gap analysis, pilot process, integration, monitoring.
Applies universally; customize to context.
No external audits required; internal reviews suffice. (178 words)

Key Differences

Aspect	GMP	ISO 31000
Scope	Manufacturing controls for product quality	Enterprise-wide risk management principles
Industry	Pharma, biologics, food, cosmetics	All industries and organization types
Nature	Mandatory enforceable regulations	Voluntary non-certifiable guidelines
Testing	Process validation, equipment qualification	Risk assessments, monitoring reviews
Penalties	Warning letters, recalls, fines	No legal penalties

Scope

GMP

Manufacturing controls for product quality

ISO 31000

Enterprise-wide risk management principles

Industry

GMP

Pharma, biologics, food, cosmetics

ISO 31000

All industries and organization types

Nature

GMP

Mandatory enforceable regulations

ISO 31000

Voluntary non-certifiable guidelines

Testing

GMP

Process validation, equipment qualification

ISO 31000

Risk assessments, monitoring reviews

Penalties

GMP

Warning letters, recalls, fines

ISO 31000

No legal penalties

Frequently Asked Questions

Common questions about GMP and ISO 31000

GMP FAQ

ISO 31000 FAQ

You Might also be Interested in These Articles...

Proving CIS Controls v8.1 Works: A KPI & Evidence Framework for Board Reporting, Audits, and Continuous Assurance

Prove CIS Controls v8.1 effectiveness with KPI catalog, evidence checklist & reporting cadence. Ideal for board reports, audits & cyber-insurance. Measure outco

NIST CSF 2.0 Implementation Tiers Roadmap: Step-by-Step Guide from Partial to Adaptive Cybersecurity Maturity

Master NIST CSF 2.0 Implementation Tiers with a step-by-step roadmap. Assess your tier, build gap analyses, and advance from Partial (Tier 1) to Adaptive (Tier

Decoding Tomorrow's Regulations: How Advanced Compliance Tools Predict and Prepare for Future Shifts

Advanced compliance tools use AI, analytics & real-time monitoring to predict regulatory shifts, cut non-compliance costs 3x, and ensure audit readiness. Stay p

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how GMP and ISO 31000 compare against other standards

Other GMP Comparisons

Other ISO 31000 Comparisons

What It Is

Key Components

5 Ps pillars: People, Premises, Processes, Procedures, Products.

Core elements: Quality Management System (PQS), validation, documentation, training, facility controls, CAPA, change control.

Built on ICH Q9/Q10 (QRM, lifecycle QMS); no fixed control count, but comprehensive subparts/chapters.

Compliance via inspections, no central certification but site approvals.

What It Is

Key Components

Three pillars: 8 principles (e.g., integrated, customized, dynamic), framework (leadership, integration, design, evaluation), and process (communication, assessment, treatment, monitoring).

No fixed controls; flexible, tailored implementation.

Built on PDCA cycle for continual improvement.

Non-certifiable; self-assessed alignment via governance and evidence.

Aspect

GMP

ISO 31000

Scope

Manufacturing controls for product quality

Enterprise-wide risk management principles

Industry

Pharma, biologics, food, cosmetics

All industries and organization types

Nature

Mandatory enforceable regulations

Voluntary non-certifiable guidelines

Testing

Process validation, equipment qualification

Risk assessments, monitoring reviews

Penalties

Warning letters, recalls, fines

No legal penalties